Condition
Oesophagus Cancer
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Unknown2
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02735057Phase 1RecruitingPrimary
Chemoradiotherapy in Elderly Patients With Oesophagus Cancer
NCT06048458Unknown
Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping
NCT02335970Not ApplicableCompletedPrimary
Effects of a Training Intervention After Thoracoabdominal Oesophagus Surgery
NCT04151524UnknownPrimary
Classification of Adenocarcinoma of the Esophagogastric Junction
Showing all 4 trials